The Experts below are selected from a list of 19431 Experts worldwide ranked by ideXlab platform
Yigal Abramowitz - One of the best experts on this subject based on the ideXlab platform.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Background: Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design: Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion: The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
-
Forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Maayan Konigstein, Arie Steinvil, Eyal Ben-assa, Eran Leshem-rubinow, Yigal AbramowitzAbstract:Background Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Trial registration Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
Zhou Mei - One of the best experts on this subject based on the ideXlab platform.
-
The effects of wood-gypsum ratio,water-gypsum ratio and temperature on the properties of the gypsum sawdust board
Journal of Nanjing Forestry University, 2008Co-Authors: Zhou MeiAbstract:The relationship between wood-gypsum ratio and water gypsum ratio was studied.The effects of temperature on Hydration process,the Hydration System and the morphology of gypsum were explored by analyzing the concentration of Ca2+ in the hydrating System and the morphology of gypsum crystals.In addition,the physical and mechanical properties of the gypsum sawdust board were analyzed.The results showed that these ratios satisfied the formula,ω=0.54x+0.28,each water-gypsum ratio has a corresponding wood-gypsum ratio to fit.The water-gypsum ratio and the corresponding wood-gypsum ratio would make the board's properties best together.These ratios satisfied when the temperature was 40℃,the gypsum Hydration time shortened and the board had high strength.The application of this condition shortened the production period and improved the efficiency.
Yaron Arbel - One of the best experts on this subject based on the ideXlab platform.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Background: Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design: Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion: The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
-
Forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Maayan Konigstein, Arie Steinvil, Eyal Ben-assa, Eran Leshem-rubinow, Yigal AbramowitzAbstract:Background Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Trial registration Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
Liguang Xiao - One of the best experts on this subject based on the ideXlab platform.
-
preparation and properties of a new composite of epoxy emulsion eem modified cement
Journal of Wuhan University of Technology-materials Science Edition, 2009Co-Authors: Liguang Xiao, Lixia GuAbstract:High performance cement based composite materials was prepared by adding epoxy emulsion. The epoxy emulsion was synthesized with epoxy phosphoric acid ester and poly-glycol in laboratory. This epoxy emulsion has advantages over other emulsion, such as dehydrated slightly, and, well film formation abilities. The mechanical properties corruptness resistance and structure of epoxy emulsion modified cement mortars were studied. Experimental results show that the mechanical properties of modified cement mortars are slightly increased with increasing epoxy emulsion content, especially the flexure strength. The corruptness resistance of all modified mortars is better than the unmodified mortar. The polymer film forms the bridge phases between the matrix and the aggregate regions, and forms a three-dimension structure in the cement Hydration System, which improves the mechanical properties of modified mortars.
-
preparation and properties of a new composite of epoxy emulsion eem modified cement
Journal of Wuhan University of Technology-materials Science Edition, 2009Co-Authors: Liguang Xiao, Yujie JinAbstract:High performance cement based composite materials was prepared by adding epoxy emulsion. The epoxy emulsion was synthesized with epoxy phosphoric acid ester and poly-glycol in laboratory. This epoxy emulsion has advantages over other emulsion, such as dehydrated slightly, and, well film formation abilities. The mechanical properties corruptness resistance and structure of epoxy emulsion modified cement mortars were studied. Experimental results show that the mechanical properties of modified cement mortars are slightly increased with increasing epoxy emulsion content, especially the flexure strength. The corruptness resistance of all modified mortars is better than the unmodified mortar. The polymer film forms the bridge phases between the matrix and the aggregate regions, and forms a three-dimension structure in the cement Hydration System, which improves the mechanical properties of modified mortars.
Arie Steinvil - One of the best experts on this subject based on the ideXlab platform.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Background: Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design: Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion: The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI.
-
forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation reduce aki study protocol for a randomized sham controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Eyal Benassa, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Eran Leshemrubinow, Maayan Konigstein, Arie Steinvil, Yigal AbramowitzAbstract:Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
-
Forced diuresis with matched Hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial
Trials, 2014Co-Authors: Yaron Arbel, Amir Halkin, Gad Keren, Arie Lorin Schwartz, Ofer Havakuk, Maayan Konigstein, Arie Steinvil, Eyal Ben-assa, Eran Leshem-rubinow, Yigal AbramowitzAbstract:Background Acute kidney injury (AKI) is observed in up to 41% of patients undergoing transcatheter aortic valve implantation (TAVI) and is associated with increased risk for mortality. The aim of the present study is to evaluate whether furosemide-induced diuresis with matched isotonic intravenous Hydration using the RenalGuard System reduces AKI in patients undergoing TAVI. Methods/Design Reduce-AKI is a randomized sham-controlled study designed to examine the effect of an automated matched Hydration System in the prevention of AKI in patients undergoing TAVI. Patients will be randomized in a 1:1 fashion to the RenalGuard System (active group) versus non-matched saline infusion (sham-controlled group). Both arms receive standard overnight saline infusion and N-acetyl cysteine before the procedure. Discussion The Reduce-AKI trial will investigate whether the use of automated forced diuresis with matched saline infusion is an effective therapeutic tool to reduce the occurrence of AKI in patients undergoing TAVI. Trial registration Clinicaltrials.gov: NCT01866800 , 30 April 30 2013.
